Phase I/II study of docetaxel and (153)Sm for castrate metastatic prostate cancer (CMPC): Summary of dose-escalation cohorts and first report on the expansion cohort Meeting Abstract

  

Authors:	Morris, M. J.; Pandit-Taskar, N.; Stephenson, R. D.; Hong, C.; Slovin, S. F.; Rathkopf, D.; Solit, D.; Carrasquillo, J.; Larson, S.; Scher, H. I.
Abstract Title:	Phase I/II study of docetaxel and (153)Sm for castrate metastatic prostate cancer (CMPC): Summary of dose-escalation cohorts and first report on the expansion cohort
Meeting Title:	45th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	27
Issue:	15 Suppl.
Meeting Dates:	2009 May 29-Jun 2
Meeting Location:	Orlando, FL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2009-05-20
Start Page:	248s
Language:	English
ACCESSION:	WOS:000276606603457
PROVIDER:	wos
DOI:	10.1200/jco.2009.27.15_suppl.5057
Notes:	Meeting Abstract: 5057 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/129691